1. Fatty Liver (NAFLD/MASH)

Fatty liver disease (NAFLD/MASH) is a metabolic condition linked to obesity, insulin resistance, and diabetes. Early stages are reversible with sustained weight loss and lifestyle changes, while advanced fibrosis requires specialist care to prevent progression to cirrhosis and liver-related complications.

2. Can Fatty Liver Be Reversed?

Yes, early-stage fatty liver can be reversed. A weight reduction of 7–10%, improved insulin sensitivity, and metabolic control are key. In selected patients, medications such as GLP-1 receptor agonists may support liver fat reduction and fibrosis improvement under specialist supervision.

3. Cirrhosis

Cirrhosis is advanced scarring of the liver caused by chronic injury from conditions like alcohol use, hepatitis, or fatty liver disease. While not fully reversible in later stages, progression can be slowed with treatment, complication prevention, and timely evaluation for liver transplantation.

4. Symptoms of Cirrhosis

Early cirrhosis may be asymptomatic. Advanced disease can present with fatigue, jaundice, abdominal swelling (ascites), confusion (encephalopathy), and gastrointestinal bleeding. Regular monitoring helps detect complications early and improves outcomes with timely medical intervention.

5. When Is Liver Transplant Needed?

Liver transplantation is considered when liver function is irreversibly impaired and complications cannot be controlled medically. Indicators include recurrent ascites, encephalopathy, variceal bleeding, and worsening MELD score. Early referral improves survival and transplant outcomes.

6. Abnormal Liver Function Tests (LFTs)

Abnormal liver tests may result from fatty liver, medications, alcohol, viral hepatitis, or metabolic disorders. Interpretation requires pattern recognition (hepatocellular vs cholestatic) and clinical correlation. Many cases are reversible, but persistent abnormalities require specialist evaluation.

7. High Bilirubin with Normal Liver Enzymes

Isolated bilirubin elevation is often benign, commonly due to Gilbert’s syndrome. However, it should be differentiated from hemolysis or early liver disease. Repeat testing and fractionation (direct vs indirect bilirubin) help guide appropriate evaluation.

8. Hepatitis B Management

Chronic hepatitis B requires long-term monitoring and, in some cases, antiviral therapy to suppress viral replication and prevent liver damage. Treatment decisions depend on viral load, liver inflammation, and fibrosis stage, with regular follow-up to reduce cancer risk.

9. Hepatitis C Cure

Hepatitis C is now curable in over 95% of patients with direct-acting antiviral therapy. Early treatment prevents progression to cirrhosis and liver cancer, making timely diagnosis and specialist-guided therapy essential.

10. Portal Hypertension

Portal hypertension refers to increased pressure in the portal vein, commonly due to cirrhosis. It can lead to variceal bleeding, ascites, and splenomegaly. Management includes medications, endoscopic surveillance, and in advanced cases, interventional procedures.

11. Ascites in Liver Disease

Ascites is fluid accumulation in the abdomen, usually due to cirrhosis and portal hypertension. Management includes salt restriction, diuretics, and monitoring for infection (spontaneous bacterial peritonitis), with advanced cases requiring specialized care.

12. Hepatorenal Syndrome

Hepatorenal syndrome is a serious complication of advanced liver disease causing kidney failure. It requires urgent treatment with vasoconstrictors, albumin, and consideration for liver transplantation, as early intervention improves survival.

13. Liver Cancer Screening

Patients with cirrhosis or chronic hepatitis B require regular screening for liver cancer using ultrasound with or without alpha-fetoprotein every 6 months. Early detection significantly improves treatment options and survival outcomes.

14. Second Opinion in Liver Disease

A second opinion is valuable when diagnosis is unclear, treatment response is poor, or major decisions like liver transplant are being considered. A structured review can clarify diagnosis, optimize therapy, and define the next clinical steps.

15. Fatty Liver vs NASH

Fatty liver (NAFLD) refers to fat accumulation in the liver, while NASH (non-alcoholic steatohepatitis) includes inflammation and liver cell injury, increasing the risk of fibrosis and cirrhosis. Differentiation is critical for prognosis and management.